Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures☆
References (31)
- et al.
Cytokines in Alzheimer's disease
Prog. Neuropsychopharmacol. Biol. Psychiatry
(1991) - et al.
β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
Brain Res.
(1992) - et al.
Interleukin-6 and α2-macroglobulin indicate an acute-phase state in Alzheimer's disease
FEBS Lett.
(1991) - et al.
Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
Anal. Biochem.
(1987) - et al.
Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1
Mol. Brain Res.
(1992) - et al.
Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development
Brain Res.
(1994) - et al.
Non-steroidal anti-inflammatory drug use in Alzheimer's disease and elderly populations
Biol. Psychiatry
(1994) - et al.
Cytokine induces in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein
Brain Res.
(1993) - et al.
Neuroanatomical localization and quantification of amyloid precursor protein mRNA in situ hybridization in the brains of normal aneuploid and lesioned mice
- et al.
Inverse association of anti-inflammatory treatments and Alzheimer's disease
Neurology
(1994)
Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer β/A4amyloid protein precursor
Interleukin-6: a cytokine for gerontologist
J. Am. Geriatr. Soc.
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35
NeuroReport
A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy
Eur. J. Neurosci.
A case-control study of dementia of the Alzheimer type
Am. J. Epidemiol.
Cited by (175)
Inflammation in obesity, diabetes, and related disorders
2022, ImmunityCitation Excerpt :Because TREM2 is a receptor for a yet-to-be-identified lipid species, it is possible that activation of TREM2 with a ligand or an activating antibody could represent a potential therapeutic approach. Similar to macrophages throughout the body, activated microglia also release a number of cytokines that may participate in AD pathogenesis (Del Bo et al., 1995; Hanisch, 2002; Heneka et al., 2013, 2015b; Smith et al., 2012). IL-1β might be the most important cytokine released in this context and is elevated in the brains of AD patients (Liu and Quan, 2018).
Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease
2021, International ImmunopharmacologyEarly neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults
2021, Brain, Behavior, and Immunity6-gingerol: A therapeutically potent lead candidate in anti-inflammatory drug discovery
2019, Discovery and Development of Anti-inflammatory Agents from Natural Products6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation
2018, Biomedicine and PharmacotherapyCitation Excerpt :Although reactive astrocytes are beneficial and important for maintaining homeostasis, it has been well demonstrated that overactivated astrocytes are detrimental in the brain [32–34]. Among the numerous proinflammatory cytokines, IL-6 is a pleiotropic interleukin and mainly synthesized and secreted by astrocytes [35]. Using IL-6 knockout mice, it has been demonstrated that IL-6 is an important mediator of LPS-induced cognitive deficits [36].
- ☆
This work was supported by Consiglio Nazionale delle Ricerche, Rome, Italy, c.n. 93.0174.CT04 and Convenzione Psicofarmacologia.